Intertos (Dextromethorphan Hydrobromide)

Dextromethorphan acts as a sigma‑1 receptor agonist and an NMDA receptor antagonist in the brainstem. This dual action reduces the transmission of cough signals, thereby lowering the frequency and intensity of the cough without affecting normal breathing.

The appropriate dose of Intertos is determined by the prescribing healthcare professional based on the patient’s age, weight, and clinical condition. Patients should follow the prescriber’s instructions and the product label for safe use.

Intertos is classified as pregnancy category B1, indicating that animal studies have not shown risk and there are no adequate human studies. It should be used only if clearly needed, and breastfeeding mothers should consult a healthcare provider before use.

To order Intertos, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Intertos (dextromethorphan) is a non‑opioid antitussive, whereas codeine is an opioid that also suppresses cough but carries a higher risk of dependence, respiratory depression and stricter regulatory control. Dextromethorphan is generally available OTC and has a more favorable safety profile for short‑term use.

Store Intertos at ambient temperature, below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight and heat sources. Ensure the container is tightly closed to maintain product stability.

Intertos is taken orally, usually as a tablet or liquid formulation, as directed by a healthcare professional. It should be swallowed with water and not chewed unless the product specifically states otherwise.

Serious risks include allergic reactions such as rash or swelling, hallucinations or other psychotic symptoms, severe respiratory depression at high doses, rare skin reactions like Stevens‑Johnson syndrome, and seizures. Patients experiencing any of these should seek immediate medical attention.

Intertos should be avoided in individuals with known hypersensitivity to dextromethorphan, those taking MAO inhibitors, patients with uncontrolled asthma or severe COPD, and children under the age recommended on the product label unless a physician advises otherwise.